Company

Mireca Medicines GmbH

Biotechnology Research Tuebingen, Baden-württemberg, De 5 employees

Employees: 5

mireca.eu LinkedIn Crunchbase

Mireca Medicines GmbH Overview

Headquarters: Tuebingen, Baden-württemberg, De
Website: mireca.eu
Industry: Biotechnology Research
Employees: 5
Founded: 2017
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Retina retinitis pigmentosa ocular drug delivery targeted drug delivery retinal degeneration Leber´s congenital amaurosis

About Mireca Medicines GmbH

Developing cGMP analog drug products - Mireca Medicines GmbH, Tübingen, is an expanding, preclinical stage company pioneering the development of proprietary cyclic guanosine monophosphate (cGMP)-analogs and drug delivery technologies to treat diseases caused by a dysregulation of cGMP, affecting protein kinase G (PKG). Mireca’s lead program focusses on the inhibition of cGMP signaling for neuroprotection and has obtained positive preclinical data for inherited retinal diseases (IRD) like Retinitis Pigmentosa (RP), Leber’s Congenital Amaurosis, and Stargardt’s disease.

Mireca Medicines GmbH Contact Details

People in AeroLeads: 3

Mireca Medicines GmbH Org Chart

Sample employees and titles

Name	Title	Location	Contact
Karo Smeele	Master Student at Leiden University	Leiden, South Holland, Netherlands	View
Natasha Collison	Scientist Product Development ~ Mireca		View
Francois Paquet-Durand	Neuroscientist and Researcher in Retinal Diseases, Consultant for Ophthalmic Drug Development	Tübingen, Baden-württemberg, Germany	View